Hemophilia 360 Summit is a focused scientific event designed to provide a comprehensive perspective on hemophilia care, integrating clinical practice with health economics and policy considerations.

The program emphasizes the growing role of Health Technology Assessment (HTA) in optimizing treatment pathways, improving patient outcomes, and ensuring sustainable healthcare delivery.

Through expert-led discussions, the meeting will explore real-world evidence, economic burden, and value-based decision -making in hemophilia management. It aims to bridge the gap between clinical innovation and healthcare systems, supporting informed strategies that enhance both patient care and resource utilization.